期刊文献+

辣椒碱多囊脂质体的制备及在大鼠体内的药动学研究 被引量:1

Preparation of Capsaicin multivesicular liposomes and its pharmacokinetics in the rats
原文传递
导出
摘要 目的制备辣椒碱多囊脂质体,并考察其包封率和在大鼠体内的药动学。方法采用复乳法制备辣椒碱多囊脂质体、单因素筛选处方,并考察大鼠sc辣椒碱多囊脂质体后的体内药动学。结果制备的辣椒碱多囊脂质体的外观圆整,大小均匀,包封率为71.9%±3.8%,平均粒径为8.1μm。大鼠sc辣椒碱多囊脂质体后,与辣椒碱溶液相比,Cmax分别为405.72±53.87、804.06±108.17 ng.mL-1;AUC0-t为16.7836±2.8541、3.7622±0.6651μg.h.mL-1;消除时间分别为32.31±2.64、3.23±0.34 h,72 h时血浆中仍可检测到药物。结论采用复乳法可成功将脂溶性药物辣椒碱载入多囊脂质体中,大鼠体内的药动学研究显示有明显的缓释特征。 OBJECTIVE To prepare Capsaicin multivesicular liposomes(MVLs) and investigate the encapsulation efficiency and the pharmacokinetics in rats.METHODS Capsaicin MVLs were prepared by double emulsion method,and optimized by single factor experiments.The pharmacokinetics of Capsaicin MVLs following subcutaneous injection in rats was studied.RESULTS Capsaicin MVLs seemed round and well-distributed with the encapsulation efficiency was 71.9%±3.8% and the average particle size was 8.1 μm.Following the subcutaneous injection in rats,the Cmax was 405.72±53.87 and 804.06±108.17 ng·mL-1;AUC0-t was 16.7836±2.8542,3.7622±0.6651 μg·h·mL-1;t1/2 was 32.31±2.64,3.23±0.34 h for Capsaicin MVLs and solution,respectively.The plasma concentration of Capsaicin maintained above the quantitative limitation 72 h after the administration of Capsaicin MVLs.CONCLUSION The lipid soluble drug Capsaicin could be successfully entrapped into the MVLs,and Capsaicin MVLs showed a significant sustained release property following subcutaneous injection in rats.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第5期401-404,共4页 West China Journal of Pharmaceutical Sciences
基金 国家十一五重大新药创制计划关键技术项目(2009ZX09503-026)
关键词 辣椒碱 多囊脂质体 药物动力学 大鼠 Capsaicin Multivesicular liposomes Pharmacokinetics Rat
  • 相关文献

参考文献3

二级参考文献29

  • 1董新荣,刘仲华,杨建奎,李霞.辣椒素类物质的化学研究进展[J].天然产物研究与开发,2004,16(5):486-489. 被引量:33
  • 2施飞群.中药辣椒中辣椒素和辣椒红素的提取[J].中草药,1994,25(5):276-276. 被引量:40
  • 3洪慧,龙晓英,李力任,林丹,梁少华.葡聚糖微型凝胶柱测定辣椒碱柔性脂质体包封率的条件探讨[J].广东药学院学报,2005,21(2):120-123. 被引量:29
  • 4[1]Wachtel RE.Translational vignette capsaicin[J].Reginal Anesthesia and Pain Medicine,1999,24(4):361-363.
  • 5[2]Caterina MJ,Leffler A,Malmberg AB,et al.Impaired nociception and pain sensation in mice lacking the capsaicin receptor[J].Science,2000,288(5464):306-313.
  • 6[3]Vogel G.Hot pepper receptor could help manage pain[J].Science,2000,288(5464):241-242.
  • 7[4]Dedov VN,Roufogalis BD.Mitochondrial calcium accumulation following activation of vanilloid (VR1) receptors by capsaicin in dorsal root ganglion neurons[J].Neuroscience,2000,95(1):183-188.
  • 8[5]Nagy I,Rang HP.Similarities and differences between the responses of rat sensory neurons to noxious heat and capsaicin[J].J Neurosci,1999,19(24):10647-10655.
  • 9[6]Purkiss J,Welch M,Doward S,et al.Capsaicin stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of tow distinct mechanisms[J].Biochem Pharmacol,2000,59(11):1403-1406.
  • 10[7]Veronesi B,Carter JD,Devlin RB,et al.Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line[J].Neuropeptides,1999,33(6):447-456.

共引文献66

同被引文献5

  • 1Meng ZQ, Tang ZH, Yan YX, et al. Study on the anti - gout activ- ity of chlorogenic acid : Improvement on hyperuricemia and gouty inflammation[ J]. Am J Chin Med ,2014,11 : 1 - 13.
  • 2Freitas DS, Spencer PJ, Vass~io RC, et al. Biochemical and biop- harmaceutical properties of PEGylated uricase [ J ]. Int J Pharm, 2010,387( 1 -2) :215 -222.
  • 3Supriya D, Beedkar CN, Ragini G, et al. Comparative structural modeling and docking studies of uricase: Possible implication in enzyme supplementation therapy for hyperuricemic disorders[ J]. Comput Biol Med,2012,42(6) :657 -666.
  • 4Ramprasad MP, Amini A, Kararli T, et al. The sustained granulo- poietic effect of progenipoietin encapsulated in multivesieular liposomes [ J ]. Int J Pharm,2003,261 ( 1 - 2 ) : 93 - 103.
  • 5Tan QY, Zhang JQ, Wang N, et al. Uricase from Bacillus fastidi- ous loaded in alkaline enzymosomes: Enhanced biochemical and pharmacological characteristics in hypourieemie rats [ J ]. Eur J Pharm Biopharm,2012,82(2012) :43 -48.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部